# T4/T3 Therapy in Hypothyroidism

> **NCT07424183** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 60 (estimated)

## Conditions studied

- Hypothyroidism Primary

## Interventions

- **DRUG:** Liothyronine (L-T3)
- **DRUG:** Levothyroxine Sodium (LT4) Tablets
- **DRUG:** Liothyronine (LT3) placebo

## Key facts

- **NCT ID:** NCT07424183
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424183, "T4/T3 Therapy in Hypothyroidism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07424183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*